Kwang Dong Pharmaceutical Co., Ltd. (KOSE: A009290)
Health Care · Pharmaceuticals · KR
₩5,950.00
-5.85% today · -0.8% 1Y
Kwang Dong Pharmaceutical Co., Ltd. (KOSE: A009290) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $157.39M.
Over the last twelve months the share price has lost 0.8%, trading between 5.15K and 12.80K.
Tweenvest scores Kwang Dong Pharmaceutical Co., Ltd. across four factors: quality 74/100, value 39/100, growth 19/100, dividend 35/100. Its strongest factor is quality.
A009290 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $157.39M
- Revenue (TTM)
- $1.10B
- P/E
- 12.43
- EPS
- 478.54
- Dividend yield
- 1.68%
- Beta (5Y)
- 0.35
- 52-week high
- ₩12,800.00
- 52-week low
- ₩5,150.00
- Avg volume (3M)
- —
- Shares outstanding
- 36.66M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,247.03 | +0.01% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $270.99 | -0.75% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.72 | +0.04% |
| Roche Holding AGSWX: ROP | $368.80B | CHF371.00 | +0.16% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.66 | +0.46% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.98 | +0.04% |
Figures last refreshed Aug 18, 2026.